Glucocorticoid therapy in assisted reproduction

Area of Science:

• Reproductive endocrinology and immunology.
• Clinical applications in assisted reproduction.

Background:

• Glucocorticoids regulate stress and immune responses, influencing reproductive functions.
• Their use in assisted reproduction, particularly in vitro fertilization (IVF), is debated.
• Existing studies lack consistency due to small, uncontrolled designs and varied criteria.

Purpose of the Study:

• To evaluate the clinical efficacy and safety of glucocorticoid therapy in IVF cycles.
• To address the controversy surrounding glucocorticoid use and endometrial receptivity.
• To determine if glucocorticoids improve pregnancy rates in unselected IVF populations.

Main Methods:

• Review of existing literature on glucocorticoid use in IVF.
• Analysis of study designs, criteria, and reported outcomes.
• Assessment of potential risks versus benefits for maternal and fetal health.

Main Results:

• No conclusive evidence supports improved pregnancy rates with glucocorticoids in unselected IVF subjects.
• Previous studies are limited by methodological weaknesses.
• The risk-benefit balance for early pregnancy exposure requires careful consideration.

Conclusions:

• Current evidence does not support routine glucocorticoid use in IVF cycles for unselected patients.
• Further well-designed studies are necessary to clarify the role of glucocorticoids in assisted reproduction.
• Careful risk-benefit evaluation is crucial before clinical application.